SI
SI
discoversearch

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor.  We ask that you disable ad blocking while on Silicon Investor in the best interests of our community.  If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.
Biotech / Medical : Oxford GlycoSciences Plc
 Public ReplyPrvt ReplyMark as Last ReadFilePrevious 10Next 10PreviousNext  
To: tuck who wrote (437)4/5/2003 1:30:46 PM
From: scaram(o)uche   of 469
 
>> But..... apart from the obvious indications, I believe that NB-GJ could have use for a variety of ACUTE indications. <<

Message 18339083

I still believe this. I think it's CRAZY that more pharmas aren't in the mix with Celltech, Merlin Bioscience, etc. They just never learn. They want to look good for their shareholders and save money when everything is cheap. The reason that Novartis is becoming dominant? During the days of Sandoz and Ciba, the focus was on a bright future rather than next quarter's bottom line.
Report TOU ViolationShare This Post
 Public ReplyPrvt ReplyMark as Last ReadFilePrevious 10Next 10PreviousNext  

HomeMailHotSubjectMarksPeopleMarksKeepersSettings
Terms Of UseContact UsCopyright/IP PolicyPrivacy PolicyAbout UsFAQAdvertise on SI
© 2025 Knight Sac Media.  Data provided by Twelve Data, Alpha Vantage, and CityFALCON News